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INTRODUCTION: REMEMBERING STEPHANIE FELDMAN
ALEONG
KATHY L. CERMINARA

I wish I were not writing this Introduction. As wonderful an issue of
the Nova Law Review as this is-and it is indeed a tour de force-it commemorates the loss of my dear friend and colleague, Stephanie Feldman
Aleong. I would gladly trade this publication opportunity to have Stephanie
back. The tragedy of her unexpected death in 2008 at the age of thirty-six
shook Nova Southeastern University's Shepard Broad Law Center to its core,
and we still sorely miss her. I'm sure we always will.
Nevertheless, we play the cards we are dealt in life, as no one knew better than Stephanie. A juvenile diabetic who coped with her disease and
overcame past tragic events with sheer force of will and a huge personality,
this tiny woman liked to credit her infinitely positive attitude to her father's
advice that "You have to fake it until you can make it." Everyone who knew
Stephanie knew how she incorporated this admonition into her life, consistently putting a positive spin on bad news and counseling others to look on
the bright side of any situation. Stephanie faced bad news countless times as
she battled melanoma this last time, from the day she first learned the diagnosis, throughout her research of treatment options, with her decision to
enroll in a clinical trial, and while preparing for anticipated discomfort as she
began the trial. Yet, "faking it until she could make it," she found the silver
lining in each cloud. Not long before she began the trial, only thirteen days
before her death, she assured her friends, family, colleagues and students that
"I am a tough little bird so I will undergo this therapy with a cheery heart and
a smile . .."
The tributes at the beginning of this issue afford the reader some
glimpse into why Stephanie was special to those of us who had the opportunity to know her.2 On personal notes, Stephanie's friends Madison Gray and
Susan Polsinelli offer snapshots of the roles that she played in their lives at
1. E-mail from Stephanie Feldman Aleong to Faculty at Nova Southeastern University
Shepard Broad Law Center (Oct. 8, 2008) (on file with author).
2.

See also James B. Levy, In Memoriam: Stephanie Feldman Aleong, 15 J. LEGAL
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(2009) (eulogizing her); Jennifer S. Bard, What We in Law Can Learn

From Our Colleagues in Medicine About Teaching Students How to Practice Their Chosen

Profession, 36 J. L. MED. & ETHICS 841, 848 (2008) (describing her as "a distinguished health
law scholar and law professor whose remarkable commitment to innovative teaching is a
model for us all"); Ani B. Satz, Disability, Vulnerability, and the Limits of Antidiscrimination,
83 WASH. L. REV. 513, 513 n.al (2008) (dedicating article to her).
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Vanderbilt University and in the Office of the State Attorney in Miami-Dade
County, Florida. Assistant Dean Carsten Evans of Nova Southeastern University's College of Pharmacy explains the important role Stephanie played
in the lives of countless Floridians as she and a team of investigators vanquished a major pharmaceutical counterfeiting operation when she was an
assistant statewide prosecutor.3 After serving the state attorney general's
office in that capacity, Stephanie moved into teaching, heading to Emory
Law School, where she was a colleague of Professor Ani Satz, whose tribute
reflects great respect and affection. Finally, Stephanie came to our law
school, where her colleagues and students found herjoie de vivre and talent
inspirational, as is evident from the tributes of Dean Bill Adams, Professors
Joel Mintz and Anthony Niedwiecki, and alumnus Anthony Stella, once one
of Stephanie's students.
In part because of her juvenile diabetes, Stephanie felt strongly about
using her academic scholarship to further combat drug counterfeiting. While
teaching her beloved Criminal Law and Lawyering Skills & Values students,
she influenced pharmacists and other health care professionals through her
directorship of our Master of Science in Health Law program. She also researched and wrote about America's flawed pharmaceutical supply chain.4
When the editors of the Law Review and I planned this issue, however,
it did not seem appropriate to narrowly focus on pharmaceutical regulation
when remembering Stephanie. Far from one-dimensional, Stephanie could
intelligently discuss, debate, and offer valuable comments on every subject
ranging from bioethics to health care policy. Therefore, it seemed most fitting to include in this issue articles on a similarly broad range of health law
topics. Thanks to hard work by the Law Review editors and staff, especially
Alyson Sincavage and David Stahl, these articles address a variety of important topics. Stephanie would be proud.
Notably, although the following articles analyze a cross-section of legal
issues in the health care industry, they all address matters that are of tremendous importance to patients. Stephanie would have liked that. Much as
cost, quality and access comprise a "three-legged stool" underpinning health
care policymaking, 5 patients' costs, the quality of care patients received, and
3. See KATHERINE EBAN, DANGEROUS DOSES: How COUNTERFEITERS ARE CONTAMINATING AMERICA'S DRUG SUPPLY (2005) (recounting and putting into context the effort, titled

"Operation Stone Cold").
4. Stephanie Feldman Aleong, Green Medicine: Using Lessons From Tort Law and
Environmental Law to Hold Pharmaceutical Manufacturers and Authorized Distributors

Liablefor Injuries Caused by Counterfeit Drugs, 69 U. PITr. L. REV. 245 (2007).
5. Thomas M. Mayo, Foreward: Nonfinancial Barriers to Health Care, 32 Hous. L.
REV. 1187, 1187 (1996).
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patients' struggles to access care concerned Stephanie. In this, she and I
were kindred spirits, so I am especially thankful that this selection of articles
reflects a patient-centric focus.
Professor Matthew Seamon, for example, attempted to choose a topic
that "Professor Aleong would acknowledge as important," 6 and he succeeded
admirably by choosing one affecting the costs patients might bear for drugs
in the future. While most patients would not know what "biologics" are,
such drugs are of tremendous importance to them. A "biologic" is a drug
"derived from a living organism or one of its products and.., manufactured"
through a genetic pathway.7 Such genetically tailored drugs could improve
the lives of hundreds of thousands of patients, and Professor Seamon urges
the development of an abbreviated path to their approval. As he himself
says, this topic would "impact [patients'] wallets." 8
Stephanie also worried about the quality of care patients received. Her
method of ensuring quality care was to ensure that patients received the prescription drugs they were supposed to receive, rather than counterfeits. Two
of the authors in this issue, Rebecca Feinberg and Shane Levesque, propose
health care system changes that would also improve the quality of care patients receive. Specifically, Ms. Feinberg addresses the problem of impaired
physicians 9 and suggests nationwide standardization of methods to prevent
impairment, identify afflicted physicians, treat them, and follow up thereafter. Mr. Levesque focuses on improving care for mentally ill prisoners upon
release from prison, in an attempt to break the cycle of recidivism. He proposes diversion programs, comprehensive discharge planning before release
from prison, and pre-release enrollment in public benefits to help ensure continuity of care upon release. There can be no doubt that taking steps to ensure that physicians are functioning at peak levels and reforming the way the
correctional system treats the mentally ill would improve the quality of care
patients receive-patients of many different types in the first instance and a
tightly circumscribed category of patients in the latter instance.
Finally, Stephanie shared my concern about the impact on patients of
America's employer-based system of health care coverage. Within this area,
6.

Matthew J. Seamon, Antitrust and the Biopharmaceutical Industry: Lessons from

Hatch-Waxman and an Early Evaluation of the Biologics Price Competition and Innovation

Act Of 2009, 34 NOVA L. REV. 629, 629 n.al (2010).
7. See id. at 649-650.
8. Id. at 629 n.al.
9. She defines an "impaired physician" as a "medical doctor who suffers from alcoholism, drug addiction, or mental illness." Rebecca Sara Feinberg, The Impaired Physician:
Medical, Legal, and Ethical Analysis with a Policy Recommendation, 34

NOVA

L. REV. 595,

598-600 (2010).
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Robert Sheres takes on one of the more perplexing puzzles arising from litigation on the part of such patients under the Employee Retirement Income
Security Act of 1974 (ERISA).' ° Although Congress enacted ERISA with
the stated goal of protecting employees in the wake of spectacular pension
plan failures, the statute's effect on employees who receive health care coverage through their employers has been far from protective. The United
States Supreme Court has narrowly interpreted the list of statutory remedies
available to patients alleging that their health insurers improperly denied
payment for treatments. The result, as Mr. Sheres concludes after reminding
the reader of the statute's pro-employee goal, "contravenes this goal by refusing to allow participants and beneficiaries to be made whole by way of
consequential damages."" His proposal that the Supreme Court revisit the
issue is a sound one, while his suggestions to those representing such patients
in the meantime are ingenious. Perhaps his article can help patients gain
access to treatments by putting some weapons in the hands of attorneys
representing them.
I cannot conclude this introduction without mentioning the contributions of two student authors about health law topics, for Stephanie loved her
students. Here, Morgan Geller and Ashley Dutko join the four authors
whose works I just described in addressing issues that could greatly impact
patients in the future. Ms. Geller analyzes a case alleging that the United
States Patent and Trademark Office acted unconstitutionally in granting patents on human genes to researchers, and Ms. Dutko writes about an important Florida statute intended to combat prescription drug abuse. Stephanie
would have been glad to see student work of such quality.
In short, just as Stephanie aimed at improving her surroundings in every
way possible during her short life, this issue of the Nova Law Review is
chock-full of scholarship aimed at improving the health care system in a variety of areas important to patients. It memorializes a terrific person who
lives on in our minds and hearts. It also reminds us that Stephanie did nothing halfway and could juggle many different balls while smiling and inspiring others to be better and to achieve more than they ever thought they could.
It reflects the variety of ways in which Stephanie continues to inspire others
to improve the health care system through public service, 2 to use the law as
10.

29 U.S.C. §§ 1001-1461 (2006).

11. Robert C. Sheres, The Need for an Equitable Revolution to "Appropriately" Remedy
Wrongfully Denied Benefits Under ERISA, 34 NOVA L. REV. 679, 710 (2010).

12. In tribute to Stephanie, Nova Southeastern University's College of Pharmacy and the
Drug Safety Institute have created an award titled the "Stephanie F. Aleong, J.D., National
Patient Safety Award" to recognize "individuals whose unique efforts have significantly advanced patient safety." See News Release, Nova Se. Univ., Two Florida Drug Inspectors
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an instrument of change,1 3 or simply to do the best job possible under any
and all circumstances.1 4 It is something she would be glad to see in print.
But I still wish I had not written this Introduction.

Receive National Patient Safety Award from Nova Southeastern University (Dec. 4, 2008),
http://nsunews.nova.edu/two-florida-drug-inspectors-receive-national-patient-safety-awardfrom-nova-southeastern-university/.
13. For example, when Stephanie and two of our colleagues teamed up to lead the
Goodwin Symposium at the law school, they chose to focus on "the impact women have had
on the law and legal profession and to outline what challenges lay ahead." Stephanie Feldman
Aleong, Olympia Duhart & linda f. harrison, Tilting the Scales: The Changing Roles of Women in the Law and Legal Practice,31 NOVA L. REV. 217, 219 (2007).
14. See, e.g., Anthony M. Stella, The Un-Taxability of Computer Software as Tangible
PersonalProperty by Florida County Governments, 34 NOVA L. REV. 281, 281 n.al (thanking
her for "unwavering guidance and mentorship"); David Stahl, The Role of the Florida Courts
in Protecting the Uninsured From Being Overchargedfor Emergency Medical Services, 33
NOVA L. REV. 269, 269 n.al (thanking her for "valuable suggestions and guidance"); Yeemee
Chan, Abolishing Capital Punishment: A Feminist Outlook and Comparative Analysis of the
Death Penalty Using Equal Protection and Gender DiscriminationLaw, 31 NOVA L. REV.
339, 339 n.al (thanking her for "wisdom and guidance"); Richard V. Blystone, School Speech
v. School Safety: In the Aftermath of Violence on School Campuses Throughout This Nation,
How Should School Officials Respond to Threatening Student Expression?, 2007 B.Y.U.
EDUC. & L.J. 199, 199 n.al (thanking her for "guidance and contributions to this project").
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